In vitro assessment of hepatotoxicity by metabolomics: a review

被引:0
|
作者
Matthias Cuykx
Robim M. Rodrigues
Kris Laukens
Tamara Vanhaecke
Adrian Covaci
机构
[1] University of Antwerp,Toxicological Centre
[2] Vrije Universiteit Brussel,Department of In Vitro Toxicology and Dermato
[3] University of Antwerp,Cosmetology
[4] University of Antwerp,Department of Mathematics and Computer Science
来源
Archives of Toxicology | 2018年 / 92卷
关键词
Metabolomics; In vitro; Liver; Hepatotoxicity; Drug-induced liver injury (DILI);
D O I
暂无
中图分类号
学科分类号
摘要
Omics technologies, and in particular metabolomics, have received an increasing attention during the assessment of hepatotoxicity in vitro. However, at present, a consensus on good metabolomics practices has yet to be reached. Therefore, in this review, a range of experimental approaches, applied methodologies, and data processing workflows are compared and critically evaluated. Experimental designs among the studies are similar, reporting the use of primary hepatocytes or hepatic cell lines as the most frequently used cell sources. Experiments are usually conducted in short time-frames (< 48 h) at sub-toxic dosages. Applied sample preparations are protein precipitation or Bligh-and-Dyer extraction. Most analytical platforms rely on chromatographic separations with mass spectrometric detection using high-resolution instruments. Untargeted metabolomics was typically used to allow the simultaneous detection of several classes of the metabolome, including endogenous metabolites that are not initially linked to toxicity. This non-biased detection platform is a valuable tool for generating hypothesis-based mechanistic research. The most frequently reported metabolites that are altered under toxicological impulses are alanine, lactate, and proline, which are often correlated. Other unspecific biomarkers of hepatotoxicity in vitro are the down-regulation of choline, glutathione, and 3-phospho-glycerate. Disruptions on the Krebs cycle are associated with increased glutamate, tryptophan, and valine. Phospholipid alterations are described in steatosis, lipo-apoptosis, and oxidative stress. Although there is a growing trend towards quality control, data analysis procedures do often not follow good contemporary metabolomics practices, which include feature filtering, false-discovery rate correction, and reporting the confidence of metabolite annotation. The currently annotated biomarkers can be used to identify hepatotoxicity in general and provide, to a certain extent, a tool for mechanistic distinction.
引用
收藏
页码:3007 / 3029
页数:22
相关论文
共 50 条
  • [1] In vitro assessment of hepatotoxicity by metabolomics: a review
    Cuykx, Matthias
    Rodrigues, Robim M.
    Laukens, Kris
    Vanhaecke, Tamara
    Covaci, Adrian
    ARCHIVES OF TOXICOLOGY, 2018, 92 (10) : 3007 - 3029
  • [2] The assessment of the potential hepatotoxicity of new drugs by in vitro metabolomics
    Quintas, Guillermo
    Castell, Jose V.
    Moreno-Torres, Marta
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [3] A high-throughput metabolomics in vitro platform for the characterization of hepatotoxicity
    Sabina Ramirez-Hincapie
    Barbara Birk
    Philipp Ternes
    Varun Giri
    Volker Haake
    Michael Herold
    Franziska Maria Zickgraf
    Andreas Verlohner
    Hans-Albrecht Huener
    Hennicke Kamp
    Peter Driemert
    Robert Landsiedel
    Elke Richling
    Dorothee Funk-Weyer
    Bennard van Ravenzwaay
    Cell Biology and Toxicology, 2023, 39 : 2899 - 2917
  • [4] A high-throughput metabolomics in vitro platform for the characterization of hepatotoxicity
    Ramirez-Hincapie, Sabina
    Birk, Barbara
    Ternes, Philipp
    Giri, Varun
    Haake, Volker
    Herold, Michael
    Zickgraf, Franziska Maria
    Verlohner, Andreas
    Huener, Hans-Albrecht
    Kamp, Hennicke
    Driemert, Peter
    Landsiedel, Robert
    Richling, Elke
    Funk-Weyer, Dorothee
    van Ravenzwaay, Bennard
    CELL BIOLOGY AND TOXICOLOGY, 2023, 39 (06) : 2899 - 2917
  • [5] Mass Spectrometry-Based Metabolomics in the Study of in vitro Drug Hepatotoxicity Evaluation
    Li, Li-Mei
    Zang, Qing-Ce
    Zhang, Rui-Ping
    Abliz, Zeper
    Journal of Chinese Mass Spectrometry Society, 2021, 42 (05): : 772 - 786
  • [6] Innovation for hepatotoxicity in vitro research models: A review
    Han, Weijia
    Wu, Qiao
    Zhang, Xiaohui
    Duan, Zhongping
    JOURNAL OF APPLIED TOXICOLOGY, 2019, 39 (01) : 146 - 162
  • [7] Metabolomics: An opportunity for systemic toxicity assessment in vitro
    Hartung, T.
    TOXICOLOGY LETTERS, 2015, 238 (02) : S37 - S37
  • [8] HIGHLIGHT REPORT: METABOLOMICS IN HEPATOTOXICITY TESTING
    Ghallab, Ahmed
    EXCLI JOURNAL, 2017, 16 : 1323 - 1325
  • [9] Impact of cell types and culture methods on the functionality of in vitro liver systems - A review of cell systems for hepatotoxicity assessment
    Kyffin, Jonathan A.
    Sharma, Parveen
    Leedale, Joseph
    Colley, Helen E.
    Murdoch, Craig
    Mistry, Pratibha
    Webb, Steven D.
    TOXICOLOGY IN VITRO, 2018, 48 : 262 - 275
  • [10] Hepatotoxicity of nutmeg: A pilot study based on metabolomics
    Cao, Zhipeng
    Xia, Wei
    Zhang, Xiaoyu
    Yuan, Huiya
    Guan, Dawei
    Gao, Lina
    BIOMEDICINE & PHARMACOTHERAPY, 2020, 131